30 Recruiting Hemophilia A Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Hemophilia A
Related Conditions
Top Recruiting Hemophilia A Studies
Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"
📍 Arkansas Children's Hospital - Hematology / Oncology — Little Rock, Arkansas
View Study & Checklist ➔Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
📍 Orthopaedic Institute for Children Site Number : 8400003 — Los Angeles, California
View Study & Checklist ➔Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A
📍 Froedtert Hospital and the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A
📍 UF Health Shands Hospital — Gainesville, Florida
View Study & Checklist ➔A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
📍 Banner MD Anderson Cancer Center- Site Number : 8400008 — Gilbert, Arizona
View Study & Checklist ➔Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults
📍 NOW Physical Therapy — Mountain View, California
View Study & Checklist ➔Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
📍 South Alabama Medical Science Foundation — Mobile, Alabama
View Study & Checklist ➔Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
📍 Boston Children's Hospital — Boston, Massachusetts
View Study & Checklist ➔Gene Therapy for Haemophilia A.
📍 St. Luke'S Regional Medical Center, Ltd — Boise, Idaho
View Study & Checklist ➔TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
📍 The University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔Liver Biopsy Following Gene Therapy For Hemophilia
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
📍 Arkansas Children's Hospital — Little Rock, Arkansas
View Study & Checklist ➔A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
📍 Center for Inherited Blood Disorders — Orange, California
View Study & Checklist ➔A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
📍 Intermountain - Primary Children's Hospital — Salt Lake City, Utah
View Study & Checklist ➔Treatment of Hemophilia A Patients With FVIII Inhibitors
📍 Arthur M. Blank Hospital — Atlanta, Georgia
View Study & Checklist ➔Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
📍 The Regents of the University of California||UC Davis Health — Rancho Cordova, California
View Study & Checklist ➔Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
📍 Orthopedic Hemophilia Treatment Center — Los Angeles, California
View Study & Checklist ➔Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
📍 UT Health San Antonio — San Antonio, Texas
View Study & Checklist ➔Hemophilia A Research Program
📍 University of Washington — Seattle, Washington
View Study & Checklist ➔Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
📍 Children's Hospital Los Angeles- Site Number : 8400005 — Los Angeles, California
View Study & Checklist ➔A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
📍 Center for Inherited Blood Disorders — Orange, California
View Study & Checklist ➔SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
📍 Children's Healthcare of Atlanta — Atlanta, Georgia
View Study & Checklist ➔ASC618 Gene Therapy in Hemophilia A Patients
📍 Arkansas Children's Hospital — Little Rock, Arkansas
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
📍 UC Davis Cancer Center — Sacramento, California
View Study & Checklist ➔A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
📍 University of Colorado Hemophilia and Thrombosis Center — Aurora, Colorado
View Study & Checklist ➔World Bleeding Disorders Registry
📍 World Federation of Hemophilia — Montreal, Quebec
View Study & Checklist ➔